Cargando…

A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection

BACKGROUND: Schistosomiasis is responsible for a considerable global disease burden. This work aimed to improve the therapeutic outcome of the only available antischistosomal drug worldwide, praziquantel (PZQ), by incorporating it into a novel carrier, “solid lipid nanoparticles (SLNs)”, to enhance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radwan, Amr, El-Lakkany, Naglaa M., William, Samia, El-Feky, Gina S., Al-Shorbagy, Muhammad Y., Saleh, Samira, Botros, Sanaa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580642/ https://www.ncbi.nlm.nih.gov/pubmed/31208446 http://dx.doi.org/10.1186/s13071-019-3563-z

Ejemplares similares

In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni
por: Mokbel, Kamal El-Din M., et al.
Publicado: (2020)

Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools
por: Sebastian-Perez, Victor, et al.
Publicado: (2020)

Antischistosomal and anti-inflammatory activity of garlic and allicin compared with that of praziquantel in vivo
por: Metwally, Dina M., et al.
Publicado: (2018)

Development of Praziquantel sulphonamide derivatives as antischistosomal drugs
por: Angeli, Andrea, et al.
Publicado: (2022)

Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis
por: El-Lakkany, Naglaa M, et al.
Publicado: (2012)

An Artemisinin Derivative of Praziquantel as an Orally Active Antischistosomal Agent
por: Dong, Lanlan, et al.
Publicado: (2014)

Screening of a PDE-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity
por: Botros, Sanaa S., et al.
Publicado: (2019)

Evaluation of Artesunate and Praziquantel Combination Therapy in Murine Schistosomiasis mansoni
por: HEGAZY, Laila Abdel Moniem, et al.
Publicado: (2018)

Resveratrol mitigates hepatic injury in rats by regulating oxidative stress, nuclear factor-kappa B, and apoptosis
por: Seif el-Din, Sayed Hassan, et al.
Publicado: (2016)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022)

Antischistosomal Activity of Trioxaquines: In Vivo Efficacy and Mechanism of Action on Schistosoma mansoni
por: Portela, Julien, et al.
Publicado: (2012)

Targeting the Schistosoma mansoni nutritional mechanisms to design new antischistosomal compounds
por: Pavani, Thaís F. A., et al.
Publicado: (2023)

Evaluation of the Anti-schistosomal Effects of Turmeric (Curcuma longa) Versus Praziquantel in Schistosoma mansoni Infected Mice
por: HUSSEIN, Atef, et al.
Publicado: (2017)

Antischistosomal activity of a calcium channel antagonist on schistosomula and adult Schistosoma mansoni worms
por: Silva-Moraes, Vanessa, et al.
Publicado: (2013)

Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
por: Amara, Rokaya O, et al.
Publicado: (2018)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
por: MENDONÇA, Adriana Maria B., et al.
Publicado: (2016)

Antischistosomal Activity of Two Active Constituents Isolated from the Leaves of Egyptian Medicinal Plants
por: Ali, Sanaa A, et al.
Publicado: (2015)

Possible carcinogenic potential of dimethyl dimethoxy biphenyl dicarboxylate in experimental animals
por: Botros, Sanaa Sabet, et al.
Publicado: (2016)

Schistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection
por: Vimieiro, Andréa Cássia Simões, et al.
Publicado: (2013)

Effect of Ketoconazole, a Cytochrome P450 Inhibitor, on the Efficacy of Quinine and Halofantrine against Schistosoma mansoni in Mice
por: Seif el-Din, Sayed Hassan, et al.
Publicado: (2013)

Antifibrotic effects of gallic acid on hepatic stellate cells: In vitro and in vivo mechanistic study
por: El-Lakkany, Naglaa M., et al.
Publicado: (2018)

Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
por: Eissa, Maha M., et al.
Publicado: (2020)

Wharton’s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis
por: Hammam, Olfat A., et al.
Publicado: (2016)

Complementary Effect of Capparis Spinosa L. and Silymarin With/without Praziquantel on Mice Experimentally Infected with Schistosoma Mansoni
por: El-Hawary, S. S., et al.
Publicado: (2018)

Relative Bioavailability of Orally Dispersible Tablet Formulations of Levo‐ and Racemic Praziquantel: Two Phase I Studies
por: Bagchus, Wilhelmina Maria, et al.
Publicado: (2018)

The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype
por: Pinto-Almeida, António, et al.
Publicado: (2015)

Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome
por: Schneeberger, Pierre H. H., et al.
Publicado: (2018)

A single locus determines praziquantel response in Schistosoma mansoni
por: Chevalier, Frédéric D., et al.
Publicado: (2023)

Corrigendum: Wharton’s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis
por: Hammam, Olfat A., et al.
Publicado: (2016)

Antischistosomal Activity of the Terpene Nerolidol
por: Silva, Marcos P.N., et al.
Publicado: (2014)

Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica
por: Xu, Jing, et al.
Publicado: (2023)

Praziquantel Treatment Decreases Schistosoma mansoni Genetic Diversity in Experimental Infections
por: Coeli, Regina, et al.
Publicado: (2013)

Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model
por: Abla, Nada, et al.
Publicado: (2017)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection
por: Minzi, Omary Mashiku, et al.
Publicado: (2021)

Antiparasitic Activity of Mirazid, Myrrh Total Oil and Nitazoxanide Compared to Praziquantel on Schistosoma mansoni: Scanning Electron Microscopic Study
por: EL-SAYAD, Mona, et al.
Publicado: (2017)

Evaluation of Antischistosomal Activities of Crude Aqueous Extracts of Artemisia annua, Nigella sativa, and Allium sativum against Schistosoma mansoni in Hamsters
por: Fadladdin, Yousef Abdal Jalil
Publicado: (2022)

Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni
por: Melman, Sandra D., et al.
Publicado: (2009)

Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms
por: Almeida, Giulliana T., et al.
Publicado: (2015)

TRP channels as potential targets for antischistosomals
por: Bais, Swarna, et al.
Publicado: (2018)

Cytokine Pattern of T Lymphocytes in Acute Schistosomiasis mansoni Patients following Treated Praziquantel Therapy
por: Silveira-Lemos, Denise, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jup63u173l0tsedtk2btugkom2